Related Experiment Video

Updated: Jun 22, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Transcatheter aortic valve replacement: a potential option for the nonsurgical patient

Jigar H Patel1, Sunil T Mathew, Thomas A Hennebry

  • 1Department of Internal Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.

Clinical Cardiology
|July 2, 2009
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) offers a feasible and effective option for patients with severe aortic stenosis denied surgery. Ongoing research and technological advancements may position TAVR as a viable alternative to traditional surgical valve replacement.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Rising incidence of aortic stenosis due to increased life expectancy.
  • High operative mortality excludes many patients from surgical aortic valve replacement.
  • Limited mortality benefit from current alternative treatments like medical therapy or valvuloplasty.

Purpose of the Study:

  • To review current transcatheter aortic valve replacement (TAVR) technology.
  • To present available outcome data for TAVR in high-risk patients.
  • To discuss the potential of TAVR as an alternative to surgical aortic valve replacement.

Main Methods:

  • Review of clinical trial data on transcatheter aortic valve replacement (TAVR).
  • Analysis of preliminary outcome data for TAVR devices.
  • Description of current TAVR technology and its application.

Main Results:

  • Transcatheter aortic valve replacement (TAVR) is demonstrated as feasible and effective in improving symptoms for patients with severe aortic stenosis.
  • Preliminary trial results indicate positive outcomes for TAVR in surgically denied patients.
  • Technical challenges and operator learning curve are noted limitations.

Conclusions:

  • Transcatheter aortic valve replacement (TAVR) shows promise for patients with severe aortic stenosis who are not candidates for surgery.
  • Continued technological advancements and operator experience are expected to enhance TAVR's efficacy.
  • TAVR may become a viable alternative to traditional surgical aortic valve replacement in the future.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...